Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

MabVax Starts Patient Dosing in MVT-1075 Radioimmunotherapy Phase 1 Clinical Trial

americanpharmaceuticalreviewJune 29, 2017

Tag: MabVax , MVT-1075 , Phase 1 Clinical Trial

PharmaSources Customer Service